Systems Biologynpj Precision OncologyPeer-reviewed
Overcoming Resistance to BRAFV600E Inhibition in Melanoma by Deciphering and Targeting Personalized Protein Network Alterations
Swetha Vasudevan, Efrat Flashner-Abramson, Heba Alkhatib…·Nataly Kravchenko‐Balasha
This study develops personalized drug combinations for BRAFV600E melanoma by analyzing patient-specific signaling networks, showing improved efficacy compared to standard therapies.
27 citations